Login OPEN ICICI 3-in-1 Account

ANUH PHARMA SHARE PRICE

Sector Pharmaceuticals
BSE 506260
NSE ANUHPHR
205.92
-2.88 (-1.38 %)
Buy
B
Sell
S
NSE BSE

Overview

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

Day Low

204.01

Day High

209.00

52 Week Low

148.50

52 Week High

245.70

All Time Low

148.50

All Time High

245.70

Open

208.00

Close

208.80

Volume

146,227

Mkt cap (Cr)

1,031.91

P/E ratio

21.79

P/B ratio

0.32%

Div yield

0.73%

6M return

-3.60%

1Y return

-7.60%

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

205.92 -1.38%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Anuh Pharma Ltd

Stock PE (TTM)

21.79

Promoter Holding

69.92%

Book Value

65.0595

ROCE

25.44%

ROE

19.49%

Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of "Bulk drugs and chemicals. The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals. It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra. The Company was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs. The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries. During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg. During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production. In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption. In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption. In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption. The erection of a new plant for manufacture of drug intermediates, was completed during the year 2010-11 and it got commissioned towards end of February, 2011. In 2012, it received WHO - PQ for Pyrazinamide & acquired R&D assets in Mahape, Navi Mumbai & got DSIR approval. In 2014, it got approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate. In 2015, it received approval of WHO - PQ for Sulfadoxine. In March 2019, the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It commissioned the new expansion project by starting commercial production in December, 2019. It received CEP for Ambroxol Hydrochloride from EDQM in 2022. In FY 2023-24, Company has enhanced production capacity from 1,500 MTPAto 1,800 MTPA at Boisar site.

Anuh Pharma share price as on 13 Jul 2025 is Rs. 205.92. Over the past 6 months, the Anuh Pharma share price has decreased by 3.6% and in the last one year, it has decreased by 7.6%. The 52-week low for Anuh Pharma share price was Rs. 148.5 and 52-week high was Rs. 245.7.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

506260

ANUHPHR

INE489G01022

Aug

Anuh Pharma Ltd FAQs

You can buy Anuh Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Anuh Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 11, 2025 03:58 PM the closing price of Anuh Pharma Ltd was Rs.205.92.

The latest PE ratio of Anuh Pharma Ltd as of Jul 11, 2025 03:58 PM is 21.79

The latest PB ratio of Anuh Pharma Ltd as of Jul 11, 2025 03:58 PM is 0.32

The 52-week high of Anuh Pharma Ltd share price is Rs. 245.70 while the 52-week low is Rs. 148.50

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 11, 2025 03:58 PM, the market cap of Anuh Pharma Ltd stood at Rs. 1,031.91 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.